Treatment of chronic hepatitis B virus infection using a mutant recombinant human β-interferon. A preliminary study

Treatment of chronic hepatitis B virus infection using a mutant recombinant human β-interferon. A preliminary study

Drug Investigation

Saved in:

Bibliographic Details
Main Authors:	Guan, R., Ng, H.S., Yap, I., Leong, S.F., Colby, C.B., Wee, A., Ho, J., Tan, L.H., Smith, R.
Other Authors:	MEDICINE
Format:	Article
Published:	2016
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/131993
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Treatment of chronic hepatitis B virus infection using a mutant recombinant human β-interferon. A preliminary study
by: Guan, R., et al.
Published: (2014)

Subcutaneously administered recombinant human β-interferon in the treatment of chronic hepatitis B virus infection
by: Guan, R., et al.
Published: (2014)

Subcutaneously administered recombinant human β-interferon in the treatment of chronic hepatitis B virus infection
by: Guan, R., et al.
Published: (2016)

Interferon monotherapy in chronic hepatitis B
by: Guan, R.
Published: (2016)

EFFECTS OF INTERFERON TREATMENT ON HBV PRE-CORE MUTANTS IN CHRONIC HEPATITIS B CARRIERS IN SINGAPORE
by: LIAU LIAN SOON
Published: (2019)

Treatment of hepatitis B surface antigen carriers in the early stage of the infection using recombinant alpha-interferon with steroid priming
by: Guan, R., et al.
Published: (2014)

The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore
by: Guan, R., et al.
Published: (2016)

The immune response of low dose recombinant DNA hepatitis B vaccine in teenagers in Singapore
by: Guan, R., et al.
Published: (2014)

Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - A preliminary study on immunogenicity
by: Yap, I., et al.
Published: (2016)

Recombinant DNA hepatitis B vaccine containing pre-S components of the HBV coat protein - A preliminary study on immunogenicity
by: Yap, I., et al.
Published: (2014)

Immunogenicity of a low dose recombinant DNA hepatitis B vaccine in healthy adults in Singapore
by: Guan, R., et al.
Published: (2014)

Next generation sequencing identifies baseline viral mutants associated with treatment response to pegylated interferon in HBeAg-positive chronic hepatitis B
by: Natthaya Chuaypen, et al.
Published: (2020)

Hepatitis B vaccination in chronic renal failure patients undergoing haemodialysis: The immunogenicity of an increased dose of a recombinant DNA hepatitis B vaccine
by: Guan, R., et al.
Published: (2014)

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
by: G. R. Foster, et al.
Published: (2018)

Decline in pulmonary function during chronic hepatitis C virus therapy with modified interferon alfa and ribavirin
by: G. R. Foster, et al.
Published: (2018)

Nonresponse to Interferon-? Based Treatment for Chronic Hepatitis C Infection Is Associated with Increased Hazard of Cirrhosis
by: Cozen M.L., et al.
Published: (2019)

A new pre-S containing recombinant hepatitis B vaccine and its effect on non-responders: A preliminary observation
by: Yap, I., et al.
Published: (2014)

Chronic hepatitis B infection in Singapore.
by: Yap, I., et al.
Published: (2014)

ULTRASTRUCTURAL AND IMMUNOHISTOCHEMICAL STUDIES ON CHRONIC HEPATITIS B BEFORE AND AFTER ALPHA-INTERFERON TREATMENT
by: JOSE FRANCIS V. ABRANTES
Published: (2020)

Hepatitis G infection and therapeutic response to interferon in HCV-related chronic liver disease
by: Chutima Pramoolsinsap, et al.
Published: (2018)

Detection of pre-S/S gene mutants in chronic hepatitis B carriers with concurrent hepatitis B surface antibody and hepatitis B surface antigen
by: Wang, Y.M., et al.
Published: (2014)

Baseline and kinetics of serum hepatitis B virus RNA predict response to pegylated interferon-based therapy in patients with hepatitis B e antigen-negative chronic hepatitis B
by: Umaporn Limothai, et al.
Published: (2020)

Baseline and on-treatment predictors of chronic hepatitis B patients receiving pegylated interferon therapy in Asia
by: Phunchai Charatcharoenwitthaya, et al.
Published: (2018)

Efficacy of pegylated interferon and ribavirin for the treatment of chronic hepatitis C, genotype 3 patients in Thailand
by: Watcharasak Chotiyaputta, et al.
Published: (2019)

Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults
by: Guan, R., et al.
Published: (2014)

Hepatitis B vaccination: Half dose recombinant DNA hepatitis B vaccine (B-Hepavac II) is as immunogenic as the full recommended dose in healthy adults
by: Guan, R., et al.
Published: (2016)

Hepatocyte hepatitis B surface antigen expression in chronic hepatitis B virus carriers in Singapore: Correlation with viral replication and liver pathology
by: Wee, A., et al.
Published: (2014)

Hepatocyte hepatitis B surface antigen expression in chronic hepatitis B virus carriers in Singapore: Correlation with viral replication and liver pathology
by: Wee, A., et al.
Published: (2016)

Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
by: Umaporn Limothai, et al.
Published: (2022)

Genetic variation in STAT4 is associated with treatment response to pegylated interferon in patients with chronic hepatitis B
by: Limothai U.
Published: (2023)

Intracellular interferon signalling pathways as potential regulators of covalently closed circular DNA in the treatment of chronic hepatitis B
by: Goh, Zhi Yi, et al.
Published: (2022)

Viral nucleotide changes in asymptomatic hepatitis B carriers undergoing interferon treatment
by: How, W., et al.
Published: (2014)

Viral nucleotide changes in asymptomatic hepatitis B carriers undergoing interferon treatment
by: How, W., et al.
Published: (2014)

Interleukin-28B Polymorphisms and Response of Chronic Hepatitis C Patients from Indonesia to Pegylated Interferon/Ribavirin Treatment
by: Juniastuti, et al.
Published: (2014)

The effect of interferon on flaviviruses in vitro: A preliminary study
by: S. Vithanomsat, et al.
Published: (2018)

A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
by: Lim, S.G., et al.
Published: (2012)

A randomized, placebo-controlled trial of thymosin-α1 and lymphoblastoid interferon for HBeAg-positive chronic hepatitis B
by: Lim, S.G., et al.
Published: (2011)

Serum proteomic profile, pre- and post-treatemnt, in chronic hepatitis b patients treated by peg-interferon alfa-2b.
by: Sunida Kuakarn
Published: (2013)

Molecular Mechanisms of Interferon Resistance Mediated by NS3, NS4A and NS4B Genes of Hepatitis C Viruses in Chronic Hepatitis C Patients Treated with Peginterferon-α and Ribavirin
by: Pattranuch Chusri
Published: (2020)

Influence of Host and Viral Factors on Patients with Chronic Hepatitis C Virus Genotype 6 Treated with Pegylated Interferon and Ribavirin: A Systematic Review and Meta-Analysis
by: Vo Duy Thong, et al.
Published: (2018)